Macromoltek is a computational drug discovery company dedicated to the advancement of antibody drug development. Macromoltek’s computational platform enhances existing antibody structures and designs completely new antibodies for existing and novel targets. By using their computational methods, Macromoltek generates drug candidates in a fraction of the time of traditional methods.